Major Histocompatibility Complex Class I Matching is Necessary but not Sufficient for Tolerance Induction to Vascularized Composite Allografts After Donor Hematopoietic Cell Transplantation.

Saved in:
Bibliographic Details
Title: Major Histocompatibility Complex Class I Matching is Necessary but not Sufficient for Tolerance Induction to Vascularized Composite Allografts After Donor Hematopoietic Cell Transplantation.
Authors: Manell E; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.; Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden., Gunes ME; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY., Merl S; Department of Pathology and Cell Biology, Columbia University, New York, NY., Patwardhan S; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY., Chauhan I; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY., Hong J; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY., Chen B; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY., Jordache P; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY., Almesalmy A; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY., Ekanayake-Alper D; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.; Department of Comparative Medicine, Yale School of Medicine, Yale University, New Haven, CT., Hajosi D; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY., Husain S; Department of Dermatology, Columbia University, New York, NY., Wuu CS; Department of Radiation Oncology, Columbia University, New York, NY., Wright M; Department of Surgery, Columbia University/New York-Presbyterian Hospital, New York, NY., Bogue J; Department of Surgery, Columbia University/New York-Presbyterian Hospital, New York, NY., Rohde C; Department of Surgery, Columbia University/New York-Presbyterian Hospital, New York, NY., Shanmugarajah K; Department of Surgery, University of Chicago, Chicago, IL., Cetrulo CL Jr; Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA., Sachs DH; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.; Department of Surgery, Columbia University/New York-Presbyterian Hospital, New York, NY., Weiner J; Department of Medicine, Columbia Center for Translational Immunology, Columbia University, New York, NY.; Department of Surgery, Columbia University/New York-Presbyterian Hospital, New York, NY.
Source: Transplantation direct [Transplant Direct] 2026 Jan 12; Vol. 12 (2), pp. e1900. Date of Electronic Publication: 2026 Jan 12 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101651609 Publication Model: eCollection Cited Medium: Print ISSN: 2373-8731 (Print) Linking ISSN: 23738731 NLM ISO Abbreviation: Transplant Direct Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2373-8731
DOI:10.1097/TXD.0000000000001900